Programme

09:00 – 12:00
Pre-Congress Course
Course leaders: Julieta Bomfim & Per Öst
The course content will be made available in the spring.

11:00 – 12:00
Nordic Hemophilia Council’s Annual General Meeting
Chair: Eva Zetterberg, Skåne’s University Hospital
Official notice will be issued separately.

11:00 – 13:30
Registration and Exhibition Opens

12:30 – 13:15
Industry-sponsored mini-sessions
Each session is limited to 25 participants. Registration links will be made available before the congress begins.

• Novo Nordisk/TBD    

• Takeda/TBD  

13:30 – 13:45
Welcome and Opening Remarks
Speaker: Maria Bruzelius

13:45 – 15:00
Liver Disorder – Haemostasis and Thrombosis
Chairs: Maria Magnusson & Hans Hemmingsson
Speakers:

• 13:50-14:15: Virginia Hernandez-Gea, Spain/Guidelines on Portal Vein Thrombosis

• 14:15-14:30: Sanna Norén, Karolinska Institutet/Novel haemostatic assays and biomarkers in patients with liver cirrhosis, the HELICS project

• 14:30-14:50: Hans Hemmingsson, Marie Sund and Tatiana von Bahr Greenwood, Karolinska Institutet/ Multidisciplinary patient case on Kasabach-Merritt Syndrome

• 14:50-15:00: Q&A

15:00 – 15:30
Coffee Break – Exhibition Area

15:30 – 16:45
Platelet Disorders and treatment
Chairs: Charlotte Gran & David Schmidt
Speakers:

• 15:35-16:05: Roger Schutgens, Utrecht, The Netherlands/An update on Glanzmann Thrombasthenia

• 16:05-16:20: Sofia Ramström, Örebro University, Sweden/Platelet function testing by flow cytometry in clinical settings – possibilities and challenges

• 16:20-16:35: David Schmidt, Local Faculty/Improving diagnostic work-up of platelet function disorders

• 16:35-16:45: Q&A

17:00 – 17:45
Guided Poster Walk
Chairs: Margareta Holmström, Andries Blokzijl & David Schmidt

17:00 – 19:00
Reception – Exhibition Area

08:00 – 09:00
Poster viewing and exhibition visit

08:00 – 08:45
Industry-sponsored mini-sessions
Each session is limited to 25 participants. Registration links will be made available before the congress begins.

• Pfizer/From Trial to Treatment Centre: Marstacimab OLE Updates and Practical Insights from the Clinic

09:00 – 10:15
Haemophilia and bleeding disorders in clinical practice
Chairs: Susanna Ranta & Petra Elfvinge
Speakers:

• 9:05-9:35: Christoph Königs, Frankfurt, Germany/Experience with novel treatment options in haemophilia in Germany

• 9:35-9:50: Maria Bruzelius, Local Faculty/FVIII-Mimetic Treatment in Acquired Haemophilia A: Insights from the Karolinska Experience

• 9:50-10:05: Karl Björk, Karolinska Institutet/Building psychological resilience in patients with chronic disease

• 10:05-10:15: Q&A

10:15 – 10:45
Coffee Break – Exhibition Area

10:45 – 12:00

Haemophilia – Laboratory Insights
Chairs: Maria Farm & Niklas Bark
Speakers:

• 10:45-10:55: Niklas Bark, Local Faculty/Evolution of the Chromogenic Assays

• 10:55-11:25: Peter Lenting, Paris, France/Assessing Haemostatic Function in Emerging Non-Factor Therapies for Hemophilia

• 11:25-11:35: Adrian Kimiaei, Local Faculty/Estimating the Haemostatic Capacity in Patients with Emicizumab

• 11:35-11:50: Tony Frisk, Local Faculty/Clinical Outcomes of Emicizumab Monitoring at Karolinska

• 11:50-12:00: Q&A

12:00 – 13:15
Lunch Break – Exhibition Area

12:20 – 13:05
Industry-sponsored mini-sessions

Each session is limited to 25 participants. Registration links will be made available before the congress begins.

• Roche/TBD 
• Sobi/TBD 

13:15 – 14:30

Thrombosis Over Time: Risk Factors, Acute Events and Residual Disease

Chairs: Joel Ohm & Tony Frisk
Speakers:

• 13:20-13:50: Kristina Gemzell Danielsson, Karolinska Institutet/A new era with bioidentical oestrogens – balancing benefits and thrombotic risk

• 13:50-14:05: Emma Bendz, Karolinska Institutet/Pulmonary embolism as a cause of cardiac arrest and death: age and sex differences

• 14:05-14:20: Gargi Gautam, Karolinska Institutet/Magnetic Resonance Direct Thrombus Imaging

• 14:20-14:30: Q&A

14:30 – 15:00
Coffee Break – Exhibition Area

15:00 – 16:15

Complexity in Thrombosis: Life-Course Determinants and Clinical Practice

Chairs: Natali Karandyszowska & Emma Skau
Speakers:

• 15:05-15:25: Per Svensson, Karolinska Institutet/Health equity in childhood and cardiovascular disease

• 15:25-15:45: Mika Skeppholm, Karolinska Institutet/Prosthetic heart valve thrombosis

• 15:45-16:05: Jonas Malmstedt, Karolinska Institutet/Primary subclavian vein thrombosis – results of treatment with early catheter-directed thrombolysis followed by decompression of the thoracic outlet

• 16:05-16:15: Q&A

16:15 – 16:30
Break – Exhibition Area

16:30 – 17:30

War, crises and haemostatic challenges

Chairs: Marjan Shafaati Lambert & Torsten Dahlén

Speakers:

• 16:30-16:50: Agneta Wikman, Karolinska Institutet/Blood preparedness in emergencies 

• 16:50-17:10: Johan von Schreeb, Karolinska Institutet/Pre-hospital blood for civilian trauma in conflicts

• 17:10-17:30: Märit Halmin, Karolinska Institutet/Challenges in blood transfusion when resources are limited

19:00 –
Congress Dinner

08:00 – 09:00
Poster viewing and exhibition visit

08:00 – 08:45

Industry-sponsored mini-sessions
Each session is limited to 25 participants. Registration links will be made available before the congress begins.

• Bayer/TBD

09:00 – 10:15

Cancer Associated Thrombosis – from mechanism to treatment
Chairs: Roza Chaireti & Axel Rosell

Speakers:

• 09:05-09:35: Anna Falanga, Milano, Italy/TBD 

• 09:35-09:45: Axel Rosell, Local Faculty/Venous thromboembolism as the first sign of malignancy

• 09.45-09:55: Lovisa Malmqvist, Karolinska Institutet/Coagulopathy in childhood acute lymphoblastic leukemia  

• 09:55-10:05: Ingrid Lundahl, Karolinska Institutet, Neutrophil extracellular trap formation in myeloproliferative neoplasms  

• 10:05-10:15: Q&A

10:15 – 10:45
Coffee Break – Exhibition Area

10:45 – 12:00

Von Willebrand Disease
Chairs: Anna Ågren & Adrian Kimiaei

Speakers:

• 10:50-11:20: Omid Seidizadeh, Milano, Italy/von Willebrand Disease: Linking Pathophysiology, Diagnostics, and Patient Management 

• 11:20-11:35: August Lundholm, Local Faculty/Insights from Approximately 300 von Willebrand Disease Genetic Investigations

• 11:35-11:50: Anna Ågren, Local Faculty/Acquired von Willebrand Disease

• 11:50-12:00: Q&A

• 11:50-12:00: Q&A

12:00 – 12:30

Poster Award and Closing Remarks

Speakers: Maria Bruzelius